The DOI matches its Crossref record; 61 of the 61 references it cites were found in a registry or an index.
β‐caryophyllene and β‐caryophyllene oxide—natural compounds of anticancer and analgesic properties
Open accessAbstract
Natural bicyclic sesquiterpenes, β‐caryophyllene (BCP) and β‐caryophyllene oxide (BCPO), are present in a large number of plants worldwide. Both BCP and BCPO (BCP(O)) possess significant anticancer activities, affecting growth and proliferation of numerous cancer cells. Nevertheless, their antineoplastic effects have hardly been investigated in vivo. In addition, both compounds potentiate the classical drug efficacy by augmenting their concentrations inside the cells. The mechanisms underlying the anticancer activities of these sesquiterpenes are poorly described. BCP is a phytocannabinoid with strong affinity to cannabinoid receptor type 2 (CB2), but not cannabinoid receptor type 1 (CB1). In opposite, BCP oxidation derivative, BCPO, does not exhibit CB1/2 binding, thus the mechanism of its action is not related to endocannabinoid system (ECS) machinery. It is known that BCPO alters several key pathways for cancer development, such as mitogen‐activated protein kinase (MAPK), PI 3K/AKT/mTOR/S6K1 and STAT 3 pathways. In addition, treatment with this compound reduces the expression of procancer genes/proteins, while increases the levels of those with proapoptotic properties. The selective activation of CB2 may be considered a novel strategy in pain treatment, devoid of psychoactive side effects associated with CB1 stimulation. Thus, BCP as selective CB2 activator may be taken into account as potential natural analgesic drug. Moreover, due to the fact that chronic pain is often an element of cancer disease, the double activity of BCP, anticancer and analgesic, as well as its beneficial influence on the efficacy of classical chemotherapeutics, is particularly valuable in oncology. This review is focused on anticancer and analgesic activities of BCP and BCPO, the mechanisms of their actions, and potential therapeutic utility.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Darnell, J. E. (1997) · Science · doi:10.1126/science.277.5332.1630 · Cited by 3,979
Pain as a global public health priority
Goldberg, D. S., & McGee, S. J. (2011) · BMC Public Health · doi:10.1186/1471-2458-11-770 · Cited by 1,471
Interactions of cyclic hydrocarbons with biological membranes.
Sikkema, J., de Bont, J. A., & Poolman, B. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37154-5 · Cited by 1,200
Beta-caryophyllene is a dietary cannabinoid.
Gertsch, J., Leonti, M., Raduner, S., Racz, I., Chen, J.-Z., Xie, X.-Q., Altmann, K.-H., Karsak, M., & Zimmer, A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803601105 · Cited by 906
Dahham, S., Tabana, Y., Iqbal, M., Ahamed, M., Ezzat, M., Majid, A., & Majid, A. (2015) · Molecules · doi:10.3390/molecules200711808 · Cited by 834
Targeting the PI3K/Akt/mTOR pathway: Effective combinations and clinical considerations
LoPiccolo, J., Blumenthal, G. M., Bernstein, W. B., & Dennis, P. A. (2008) · Drug Resistance Updates · doi:10.1016/j.drup.2007.11.003 · Cited by 801
Modulation of transmitter release via presynaptic cannabinoid receptors
Schlicker, E., & Kathmann, M. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01805-8 · Cited by 671
NF-κB and cancer — identifying targets and mechanisms
Naugler, W. E., & Karin, M. (2008) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2008.01.020 · Cited by 636
Fernandes, E. S., Passos, G. F., Medeiros, R., da Cunha, F. M., Ferreira, J., Campos, M. M., Pianowski, L. F., & Calixto, J. B. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.04.059 · Cited by 593
Ibrahim, M. M., Porreca, F., Lai, J., Albrecht, P. J., Rice, F. L., Khodorova, A., Davar, G., Makriyannis, A., Vanderah, T. W., Mata, H. P., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409888102 · Cited by 521
Cited by
Terpene Derivatives as a Potential Agent against Antimicrobial Resistance (AMR) Pathogens
Mahizan, N. A., Yang, S.-K., Moo, C.-L., Song, A. A.-L., Chong, C.-M., Chong, C.-W., Abushelaibi, A., Lim, S.-H. E., & Lai, K.-S. (2019) · Molecules · doi:10.3390/molecules24142631 · Cited by 473
Medicinal properties of terpenes found in Cannabis sativa and Humulus lupulus
Nuutinen, T. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.07.076 · Cited by 285
Fibromyalgia: Recent Advances in Diagnosis, Classification, Pharmacotherapy and Alternative Remedies
Maffei, M. E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21217877 · Cited by 150
Fiorini, D., Scortichini, S., Bonacucina, G., Greco, N. G., Mazzara, E., Petrelli, R., Torresi, J., Maggi, F., & Cespi, M. (2020) · Industrial Crops and Products · doi:10.1016/j.indcrop.2020.112688 · Cited by 102
Nguyen, L. T., Myslivečková, Z., Szotáková, B., Špičáková, A., Lněničková, K., Ambrož, M., Kubíček, V., Krasulová, K., Anzenbacher, P., & Skálová, L. (2017) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2017.10.021 · Cited by 67
Metadata
- Authors
- Fidyt, K., Fiedorowicz, A., Strządała, L., & Szumny, A.
- Venue
- Cancer Medicine
- Publisher
- Wiley
- Published
- 2016-09-30
- Volume
- 5
- Issue
- 10
- Pages
- 3007-3017
- ISSN
- 2045-7634 (ISSN-L)
- OpenAlex
- W2528847034
- Cited by
- 674
- References
- 61
- FWCI
- 9.58
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: β‐caryophyllene and β‐caryophyllene oxide—natural compounds of anticancer and analgesic properties. https://app.cochat.ai/papers/10.1002/cam4.816
- The paper
- Fidyt, K., Fiedorowicz, A., Strządała, L., & Szumny, A. (2016). β‐caryophyllene and β‐caryophyllene oxide—natural compounds of anticancer and analgesic properties. Cancer Medicine. https://doi.org/10.1002/cam4.816
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.